Systematic analysis identifies REST as an oncogenic and immunological  biomarker in glioma

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

4.5
(229)
Write Review
More
$ 10.00
Add to Cart
In stock
Description

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer - Computational and Structural Biotechnology Journal

IJMS, Free Full-Text

Cancers, Free Full-Text

Differential Expression Profile of NLRs and AIM2 in Glioma and

Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer

CD4 Polyclonal Antibody (19068-1-AP)

The oligonucleotide primer sequences and param- eters used in

Cancers, Free Full-Text

REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer

Sarcoma inoculation enhanced REST mRNA level in mice spinal cord